USPTO serial 88104068
E
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 23, 2020
- Examiner
- WELLS, KELLEY L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with E?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Milwaukee, WI, US
Milwaukee, WI, US
Milwaukee, WI, US
EVERSANA LIFE SCIENCE SERVICES, LLC
MILWAUKEE, WI, US
Other trademarks owned by EVERSANA LIFE SCIENCE SERVICES, LLC
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consultation services in the health care and biopharma industry; market research services, for drug companies, biologic companies, medical device companies, or other companies in the healthcare field; clinical trial referral services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; call-center support services, namely, operation of telephone call centers for others; business services provided to the life sciences, biopharmaceutical, and medical technology industries, namely, reporting and collecting biopharmaceutical and medical technology product complaints; business consulting services in the life sciences field; business management services in the healthcare field; import and export agency services; providing advertising, marketing and promotional services for the pharmaceutical and medical industry; operation of telephone call centers for others in the field of pharmaceutical, biotechnology, medical devices and healthcare manufactures; providing an online database featuring information as to the availability of pharmaceutical, biotechnology, medical devices healthcare and life sciences goods and services for purchase; patient relationship management services; advertising, promotion, and marketing services for the pharmaceutical, biotech and medical industries; pharmaceutical services, namely, processing online and telephone prescription orders in specialty pharmacies; pharmaceutical cost management services and drug utilization review services; mail order pharmacy services; business consulting services in the life sciences field; business management services in the life sciences field; providing an on-line computer database featuring trade information in the field of pharmaceutical, biotechnology and healthcare manufacturer product pricing, reimbursement data and assistance, and management of copays; providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals and life sciences; patient assistance program support services, namely, customer service management for others; retail and specialty retail pharmacy services | ACTIVE | Jan 1, 2019 |
| 036 | Financial services, namely, financial analysis and payer reimbursement, namely, reimbursement payment processing in the field of biopharmaceutical and medical technology products claims; providing a website featuring patient healthcare benefit verification services, patient reimbursement and insurance coverage for pharmaceuticals and medical devices; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers and payors; online information services, namely, providing information on insurance formulary coverage changes provided by healthcare companies to external stakeholders such as healthcare providers and patients, and receiving input about insurance plan formulary coverage or policy changes from a user via an online portal and populating pre-existing templates of materials for external audiences; providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs; financial administration of pharmacy reimbursement programs and services; pharmaceutical benefit management services | ACTIVE | Jan 1, 2019 |
| 038 | Communications services, namely, transmission of voice, audio, visual images and data by telecommunications networks, wireless communication networks, the Internet, information services networks and data networks in the field of managed healthcare markets; electronic data interchange services in the field of healthcare transactions such as claims, eligibility, claim status, electronic remittance advice, prior authorizations, attachments and referrals that allow direct transaction and payment communications between healthcare providers and payers | ACTIVE | Jan 1, 2019 |
| 039 | Supply chain services, namely, warehousing and transportation and delivery of goods for others by air, rail, ship, truck; pharmacy packaging services that aligns, sorts and packages a patient's medications by date and time into individual packets; reverse logistics packaging services, namely, packing of goods of others for shipment purposes | ACTIVE | Jan 1, 2019 |
| 042 | Research and testing services in the field of pharmaceutical, biotechnology, medical devices and healthcare manufactures; medical research; conducting clinical trials for others in the life sciences, biopharmaceutical, and medical technology fields; providing a website featuring technology to allows users to determine a patient's healthcare benefit verification services, a patient's prescription medication co-payment, to process insurance company approvals and to verify prescription medications; computer software consultancy rendered to pharmaceutical companies in the field of drug pricing and medical device pricing; providing a web hosting platform for hosting virtual advisory boards, speaker trainings and peer-to-peer programs for stakeholders in the health care community, namely, medical and pharmaceutical suppliers, healthcare professionals and payer representatives | ACTIVE | Jan 1, 2019 |
| 044 | Consulting services in the field of healthcare for pharmaceutical, biotechnology and healthcare manufactures; health care services, namely, managed health care services; pharmaceutical advice; dispensing pharmaceuticals; maintaining patient medical records and files; providing information to patients in the field of administering medications; provision of healthcare information in the field of physician groups services, health systems and hospitals, HMOs and insurance providers, regional market data, drug product and customer response data; patient support services and patient advocacy services, namely, providing health care information by telephone; patient support services, namely, medical consultations provided via phone, online chat or videoconferencing; patient support services and patient advocacy services, namely, consulting services in the field of health; health care services, namely, disease management programs | ACTIVE | Jan 1, 2019 |
| 045 | Providing licensing, regulatory, and compliance services, namely, licensing of intellectual property, regulatory compliance consulting in the life sciences, biopharmaceutical, and medical technology fields, reviewing standards and practices to assure compliance with food and drug industry laws and regulations; providing patient advocate services to hospital patients and patients in long term care facilities; Providing patient advocate services to individuals in need of medical and health care services; Providing case management services, namely, coordinating legal, medical, physical, social, personal care and psychological services in the field of health care, acute and chronic disease management, long-term care, cancer treatment, and medical treatment; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication | ACTIVE | Jan 1, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LSCS Holdings, Inc.
- Other trademarks owned by LSCS Holdings, Inc.
- Other trademarks owned by LSCS Holdings, Inc.
- Other trademarks owned by EVERSANA LIFE SCIENCE SERVICES, LLC
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 038
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named E
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 18, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Dec 23, 2025 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Sep 5, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 23, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 28, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Mar 28, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 28, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 28, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 28, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 28, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 12, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jun 23, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 19, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| May 16, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Apr 24, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 24, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 9, 2020 | IUAF | USE AMENDMENT FILED | — |
| Apr 9, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 12, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 12, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 12, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 12, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 12, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 23, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 21, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 21, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 21, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 27, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 2, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 2, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 12, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 24, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 24, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 24, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 24, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 24, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 23, 2019 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 14, 2019 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 26, 2019 | ALIE | ASSIGNED TO LIE | — |
| Apr 15, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 19, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 13, 2018 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 12, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 7, 2018 | NWAP | NEW APPLICATION ENTERED | — |